FDA Inspection 1283814 — Nanhai Beisha Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanhai Beisha Pharmaceutical Co., Ltd. on September 19, 2025 in Nanhai, Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 19, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Nanhai, Foshan (China)